PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-04-08

Date Title Company
08-Apr-2022 Ligand Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Businesswire
08-Apr-2022 Medical Fish-Skin Company Kerecis Introduces MariGen Expanse at the SAWC Conference Businesswire
08-Apr-2022 Infinity Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Businesswire
08-Apr-2022 Seagen Announces Jury Award in Patent Infringement Case Against Daiichi Sankyo Businesswire
08-Apr-2022 Global Explosion Proof Mobile Communication Devices 2022 Market Report - Players Include Getac Technology, Panasonic and Xplore Technologies Among Others - ResearchAndMarkets.com Businesswire
08-Apr-2022 Seagen to Highlight Preclinical Data for Enfortumab Vedotin and Two Novel Antibody-Drug Conjugates at AACR Annual Meeting Businesswire
08-Apr-2022 Immunomic Therapeutics Reports Preclinical Data on Its MCPγV-LT and Her2/Neu DNA Vaccines at the American Association for Cancer Research (AACR) Annual Meeting 2022 Businesswire
08-Apr-2022 AbCellera Presents Data on T Cell Engager Platform at AACR 2022 Businesswire
08-Apr-2022 Tachyon Presents Preclinical Data on the Company’s Novel KDM4 inhibitor, TACH101, at the 2022 AACR Annual Meeting Businesswire
08-Apr-2022 Qihan Biotechnology Presents Preclinical Data at American Association for Cancer Research Annual Meeting 2022 Businesswire
08-Apr-2022 MEI Pharma Announces Two Presentations at the American Association for Cancer Research Annual Meeting 2022 Businesswire
08-Apr-2022 PathAI Announces Upcoming Presentations at the 2022 American Association for Cancer Research (AACR) Annual Meeting Businesswire
08-Apr-2022 Catamaran Bio Presents Preclinical In Vivo Efficacy Data Supporting Advancement of CAT‑179, a HER2-targeted Allogeneic CAR-NK Cell Therapy Businesswire
08-Apr-2022 Palleon Presents Preclinical Data on Lead Program E-602 and Novel Bifunctional PD-L1-Targeted Sialidase Businesswire
08-Apr-2022 Bicycle Therapeutics to Present Interim BT8009 Phase I Clinical Trial Results at the 2022 AACR Annual Meeting Businesswire
08-Apr-2022 Catamaran Bio Presents Preclinical In Vivo Efficacy Data Supporting Advancement of CAT-179, a HER2-targeted Allogeneic CAR-NK Cell Therapy Businesswire
08-Apr-2022 Asher Bio to Present New Preclinical Data Demonstrating Differentiated Profile of AB248, its Lead Cis-targeted IL-2 Immunotherapy, at AACR Annual Meeting Businesswire
08-Apr-2022  Asher Bio to Unveil Two New Immunotherapy Programs, a CD8+ T Cell Targeted IL-21 and a Cis-Targeted IL-2 for Cell Therapy Augmentation, at AACR Annual Meeting Businesswire
08-Apr-2022 Imvax Presents New Data on Tumor-Derived Immunotherapies in Glioblastoma, Other Solid Tumors at AACR Annual Meeting 2022 Businesswire
08-Apr-2022 Orphagen Pharmaceuticals Presents Preclinical Efficacy Data at AACR 2022 on OR-449, a First-in-Class Steroidogenic Factor 1 Inhibitor, for the Treatment of Leydig Cell Tumors Businesswire